Cancer and pregnancy: The medical oncologist's point of view;Cancer et grossesse: Le point de vue du chimiothérapeute

Bulletin du Cancer

Volumn 89, Issue 9, 2002, Pages 779-785

  Pautier, Patricia ^a   Lhomme, Catherine ^a   Morice, Philippe ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer; Chemotherapy; Pregnancy

Indexed keywords

AMINOPTERIN; AMSACRINE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; BUSULFAN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; FLUOROURACIL; MERCAPTOPURINE; METHOTREXATE; PROCARBAZINE; VINBLASTINE;

BLEEDING; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; FEMALE; FERTILITY; FETUS; FETUS MALFORMATION; FETUS RISK; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GONAD DYSFUNCTION; HUMAN; INTELLECTUAL IMPAIRMENT; INTRAUTERINE INFECTION; LEUKEMIA; LYMPHOMA; MEDICAL DECISION MAKING; MUTAGENICITY; ORGANOGENESIS; PREGNANCY; PRENATAL EXPOSURE; REVIEW; SECOND CANCER; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; LEUKEMIA; LYMPHOMA; MEDICAL ONCOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC;

EID: 0036748128     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Donegan WL. Cancer and pregnancy. CA Cancer J Clin 1983; 33: 194-214.
2. Nieminen U, Remes N. Malignancy during pregnancy. Acta Obstet Gynecol Scand 1970; 49: 315-31.
3. Haas JF. Pregnancy in association with a newly diagnosed cancer: a population-based epidemiologic assessment. Int J Cancer 1984; 34: 229-235.
4. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989; 16: 337-46.
5. Sutcliffe SB. Treatment of neoplastic disease during pregnancy: maternal and fetal effects. Clin Invest Med 1985; 8: 333-8.
6. Schaison G, Jacquillat C, Auclerc G, Weil M. Les risques fœtoembryonnaires des chimiothérapies. Bull Cancer 1979; 66: 165-7.
7. Nicholson HO. Cytotoxic drugs in pregnancy: review of reported cases. J Obstet Gynaecol Br Commonw 1968; 75: 307-12.
8. Beeley L. Adverse effects of drugs in the first trimester of pregnancy. Clin Obstet Gynecol 1986; 13: 177-95.
9. Blatt J, Mulvihill JJ, Ziegler JL, Young RC, Poplack DG. Pregnancy outcome following cancer chemotherapy. Am J Med 1980; 69: 828-32.
10. Sweet DLJ, Kinzle J. Consequences of radiotherapy and antineoplastic therapy for the fetus. J Reprod Med 1976; 17: 241-6.
11. Doll DC, Ringenberg QS, Yarbto JW. Management of cancer during pregnancy. Arch Intern Med 1988; 148: 2058-64.
12. Caligiuri MA, Mayer RJ. Pregnancy and leukemia. Semin Oncol 1989; 16: 388-96.
13. Jones RT, Weinerman BH. MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) given during pregnancy. Obstet Gynecol 1979; 54: 477-8.
14. Garber JE. Long-term follow-up of children exposed in utero to antineoplastic agents. Semin Oncol 1989; 16: 437-44.
15. Aviles A, Niz J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Med Pediatr Oncol 1988; 16: 3-6.
16. Willemse PH, van der Sijde R, Sleijfer DT. Combination chemotherapy and radiation for stage IV breast cancer during pregnancy. Gynecol Oncol 1990; 36: 281-4.
17. Partridge AH, Garber JE. Long-term outcomes of children exposed to antineoplastic agents in utero. Semin Oncol 2000; 27: 712-26.
18. Williams SF, Schilsky RL. Antineoplastic drugs administered during pregnancy. Semin Oncol 2000; 27: 618-22.
19. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987; 5: 1098-1106.
20. Turchi JJ, Viliasis C. Anthracyclines in the treatment of malignancy in pregnancy. Cancer 1988; 61: 435-40.
21. Herbst AL, Ulfeldet H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971; 284: 878-81.
22. Mucklow JC. The fate of drugs in pregnancy. Clin Obstet Gynaecol 1986; 13: 161-75.
23. Krauer B, Krauer F. Drug kinetics in pregnancy. Clin Pharmacokinet 1977; 2: 167-81.
24. Redmond GP. Physiological changes during pregnancy and their implications for pharmacological treatment. Clin Invest Med 1985; 8: 317-22.
25. Wiebe VJ, Sipila PE. Pharmacology of antineoplastic agents in pregnancy. Crit Rev Oncol Hematol 1994; 16: 75-112.
26. Pirani BBK, Campbell PM, MacGillivray I. Plasma volume in normal first pregnancy. Br J Obstet Gynecol 1973; 80: 884-7.
27. Zenk KE. An overview of perinatal clinical pharmacology. Clin Lab Med 1981; 1: 361-75.
28. Mulvihill JJ, McKeen EA, Rosner F, Zarrabi MH. Pregnancy outcome in cancer patients. Experience in a large cooperative group. Cancer 1987; 60: 1143-50.
29. Swerdlow AJ, Jacobs PA, Marks A, Maher EJ, Young T, Barber JC, et al. Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations. Br J Cancer 1996; 74: 291-6.
30. Velentgas P, Daling JR, Malone KE, Weiss NS, William MA, Self SG, et al. Pregnancy after breast carcinoma: outcomes and influence on mortality. Cancer 1999; 85: 2424-32.
31. Surbone A, Perrek JA. Childbearing issues in breast carcinoma survivors. Cancer 1997; 79: 1271-8.
32. Gelber S, Coates AS, Goldhirsch A, Castiglione-Gertsch M, Marini G. International Breast Cancer Study Group. Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer. J Clin Oncol 2001; 19: 1671-5.
33. Berkowitz RS, Tuncer ZS, Bernstein MR, Goldstein. Management of gestational rrophoblastic diseases: subsequent pregnancy experience. Semin Oncol 2000; 27: 678-85.
34. Robbins WA, Meistrich ML, Moore D, Hagemeister FB, Weier HU, Cassel MJ, et al. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nature Genet 1997; 16: 74-8.
35. Tease C. Radiation- and chemically-induced chromosome aberrations in mouse oocytes: a comparison with effects in males. Mutat Res 1992; 296: 135-42.
36. Russell LB, Russell WL. Frequency and nature of specific-locus mutations induced in female mice by radiation and chemicals: a review. Mutat Res 1992; 296: 107-27.
37. Ashwood-Smith MJ, Edwards RG. DNA repair by oocytes. Mol Hum Reprod 1996; 2: 46-51.
38. Dodds L, Martett LD, Tomkins DJ, Gteen B, Sherman G. Case-control study of congenital anomalies in children of cancer patients. Br Med J 1993; 307: 164-8.
39. Wallack MK, Wolf JAJ, Bedwinek J, Denes AE, Glasgow G, Kumar B, et al. Gestational carcinoma of the female breast. Curr Probl Cancer 1983; 7: 1-58.
40. Moore HC, Fostet RS Jr. Breast cancer and pregnancy. Semin Oncol 2000; 27: 646-53.
41. Petrek JA, Dukoff R, Rogatko A. Prognosis of pregnancy-associated breast cancer. Cancer 1991; 67: 869-72.
42. Gallenberg MM, Loprinzi CL. Bteast cancer and pregnancy. Semin Oncol 1989; 16: 369-76.
43. Giacalone PL, Laffargue F, Benos P. Chemotherapy for breast carcinoma during pregnancy: a French national survey. Cancer 1999; 86: 2266-72.
44. Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Time since childbirth and prognosis in primary breast cancer: population based study. Br Med J 1997; 315: 851-5.
45. Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO. Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 1996; 38: 305-11.
46. Brell J, Kalaycio M. Leukemia in pregnancy. Semin Oncol 2000; 27: 667-77.
47. Ebert U, Löffler H, Kirch W. Cytotoxic therapy and pregnancy. Pharmacol Ther 1997; 74: 207-20.
48. Haggstrom J, Adriansson M, Hybbinette T, Harnby E, Thorbert G. Two cases of CML treated with alpha-interferon during second and third trimester of pregnancy with analysis of the drug in the new-born immediately postpartum. Eur J Haematol 1996; 57: 101-2.
49. Catlin EA, Roberts JD Jr, Erana R, Preffer FI, Ferry JA, Kelliher AS, et al. Transplacental transmission of narural-killer-cell lymphoma. N Engl JMed 1999; 341: 85-91.
50. Ward FT, Weiss RB. Lymphoma and pregnancy. Semin Oncol 1989; 16: 397-409.
51. Dhedin N, Coiffier B. Lymphoma in the elderly and in pregnancy. In Canellos GP, Lister TA, Skalr JL (eds): The lymphomas. Philadelphia, PA, Saundets, 1998, pp 549-56.
52. Zanotti KM, Belinson JL, Kennedy AW. Treatment of gynecologic cancers in pregnancy. Semin Oncol 2000; 27: 686-98.
53. Otton G, Higgins S, Phillips KA, Quinn M. A case of early-stage epithelial ovarian cancer in pregnancy. Int J Gynecol Cancer 2001; 11: 413-7.
54. Sood AK, Shahin MS, Sorosky JI. Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy. Gynecol Oncol 2001; 83: 599-600.
55. Kai S, Kohmura H, Hiraiwa E, Koizumi S, Ishikawa, Kawano S, et al. Reproductive and developmental toxicity studies of paclitaxel: intravenous administration to rats during the prenatal and lactation periods. J Toxicol Sci 1994; 19: 93-111.
56. Janne PA, Rodriguez-Thompson D, Metcalf DR, Swanson SJ, Greisman HA, Wilkins-Haug L, et al. Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment duting pregnancy. Oncology 2001; 61: 175-83.
57. Tebes S, Cardosi R, Hoffman M. Liposarcoma complicating pregnancy. Gynecol Oncol 2001; 83: 610-2.
58. Merimsky O, Le Chevalier T, Missenard G, Lepecheux C, Cojean-Zelek I, Mesutolle B, et al. Management of cancer in pregnancy: a case of Ewing's sarcoma of the pelvis in the thitd trimester. Ann Oncol 1999; 10: 345-50.